Issuu on Google+

ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email!

Asthma Market Forecast Published on September 2012

Report Summary The asthma market has seen strong growth, with increased uptake of relatively expensive combination products. This trend is expected to change in the near future as sales growth will slow, and even turn negative, as key products face generic entry. However, by 2021, Datamonitor forecasts a return to positive growth such that the market will maintain value, with a CAGR over 2012'21 of 0.1%.Access Datamonitor's patient-based asthma market forecast for the seven major markets, with transparent methodology and clear assumptions.Understand how market dynamics are changing and which drug classes will be most impacted in the next 10 years.Gain insight into how late-stage pipeline products will change the market and which currently marketed products are insulated against brand erosion.See how generics will impact the asthma market and gain insight into which drug classes are the most vulnerable.Datamonitor forecasts four new product launches in asthma over the next 10 years. New products for asthma across the seven major markets will counteract generic erosion and help the market to maintain value. Datamonitor forecasts the asthma market to increase from $15.0bn in 2012 to $15.1bn by 2021, representing a 2012'21 CAGR of 0.1%.The impact of generics will vary considerably by drug class. The antileukotriene class is expected to see a rapid decline as Singulair succumbs to generic entry. However, Datamonitor expects a relatively low impact of generics on inhaled combination products, although price discounting and patient switching will vary by country.While the ICS/LABA class will remain unrivalled as the most profitable in asthma, it will see significant changes. The first ICS/LABA generics are expected to enter the market from 2013. However, greater patient switching is expected from current market leaders to the first once-daily ICS/LABAs, than to generics.How can generics compete with new product launches in the ICS/LABA class'How will current market leaders be impacted by additional product launches and which products will resist brand erosion'How are class dynamics changing in asthma and which drug classes will be the most profitable in 2021'How do asthma markets differ across the seven major markets and how will these markets react to events over the next 10 years'

Table of Content OVERVIEW'Summary OVERVIEW'This product contains patient-based asthma market and product forecasts for the seven major markets (the US, Japan, France, Germany, Italy, Spain, and the UK) over 2012 to 2021. It has been designed for delivery in an Excel data pack format, but for more detail about this disease area please see the accompanying Market and Product Forecasts: Asthma (HC000219-004) PDF document and PowerPoint executive presentation. - The associated report and PowerPoint presentation can be found under Latest Research in the Knowledge Center, through the search function, or by contacting your sales representative. - Please select the data pack option from the download menu at the side of the page to access the model. - Introduction - Features and benefits - Highlights - Key questions answered in this report 'Forecasting methodology 'Disclaimer

Asthma Market Forecast (From Issuu)

Page 1/4


ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email! Companies Mentioned

Asthma Market Forecast (From Issuu)

Page 2/4


Find Industry reports, Company profiles and Market Statistics

ReportLinker

>> Get this Report Now by email! Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to: ƒ ƒ

Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93

If you have any questions please visit http://www.reportlinker.com/notify/contact

Order Information Please verify that the product information is correct and select the format(s) you require. Asthma Market Forecast

Product Formats Please select the product formats and the quantity you require.

1 User License--USD 11 400.00

Quantity: _____

Contact Information Please enter all the information below in BLOCK CAPITALS

Title:

Mr

Mrs

Dr

Miss

Ms

Prof

First Name:

_____________________________ Last Name: __________________________________

Email Address:

__________________________________________________________________________

Job Title:

__________________________________________________________________________

Organization:

__________________________________________________________________________

Address:

__________________________________________________________________________

City:

__________________________________________________________________________

Postal / Zip Code:

__________________________________________________________________________

Country:

__________________________________________________________________________

Phone Number:

__________________________________________________________________________

Fax Number:

__________________________________________________________________________

Asthma Market Forecast (From Issuu)

Page 3/4


Find Industry reports, Company profiles and Market Statistics

ReportLinker

>> Get this Report Now by email! Payment Information Please indicate the payment method, you would like to use by selecting the appropriate box.

Payment by credit card

Card Number: ______________________________________________

Expiry Date

__________ / _________

CVV Number _____________________

Card Type (ex: Visa, Amex…) _________________________________

Payment by wire transfer

Crédit Mutuel RIB : 10278 07314 00020257701 89 BIC : CMCIFR2A IBAN : FR76 1027 8073 1400 0202 5770 189

Payment by check

UBIQUICK SAS 16 rue Grenette – 69002 LYON, FRANCE

Customer signature:

 

Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at http://www.reportlinker.com/index/terms

Please fax this form to: Europe, Middle East and Africa : + 33 4 37 37 15 56

ƒ ƒ

Asthma Market Forecast (From Issuu)

Asia, Oceania and America : + 1 (805) 617 17 93

Page 4/4


Asthma Market Forecast